• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
HUANG Yayu,LIN Mini,CAI Shuyun,YAN Guangyu,CHEN Weizhu,ZHANG Yiping.Progress of research on the effect of Fucoidan on gut microflora and chronic renal failure[J].Journal Of Pharmaceutical Research,2023,42(8):599-604[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2693times   Download 2430次 QR Code for this article
Scan with your phone!
岩藻多糖对肠道菌群与慢性肾衰竭作用研究进展
黄雅瑜1,2,林米妮1,2,蔡树芸1,2,阎光宇3,陈伟珠2,张怡评1,2,3
Font:Larger+|Default|Smaller-
(1.福建中医药大学药学院,福建 福州 350108;2.自然资源部第三海洋研究所,海洋生物资源开发利用工程技术创新中心,福建 厦门 361005;3.厦门海洋职业技术学院海洋生物学院,福建 厦门 361100)
摘要:
岩藻多糖具有抗氧化、抗炎、抗凝血等功效,已成为研究热点。慢性肾功能衰竭(CRF)近年来发病率逐年上升。肠-肾轴研究发现肠道菌群(GM)与CRF之间存在双向调节。GM能够通过平衡内稳态调控机体健康,已成为治疗CRF潜在新靶点。岩藻多糖被作为一种微生物调节剂能干预GM失调进而控制CRF进程,预防加速肾衰竭潜在的危险因素。因此,本文探讨岩藻多糖对GM和CRF作用及GM与CRF双向调节机制,为后续岩藻多糖的开发和利用提供研究方向与思路。
关键词:  岩藻多糖  肠道菌群  慢性肾功能衰竭
DOI:10.13506/j.cnki.jpr.2023.08.012
基金项目:福建省科技计划项目(No.2021N0029);自然资源部第三海洋研究所基本科研业务专项资金资助项目(No.2022006);福建省海洋经济发展资金项目(No.FJHJF-L-2021-4);厦门海洋研究开发院共建项目(No.K210103)
Publication Date:August 25, 2023
Progress of research on the effect of Fucoidan on gut microflora and chronic renal failure
HUANG Yayu1,2,LIN Mini1,2,CAI Shuyun1,2,YAN Guangyu3,CHEN Weizhu2,ZHANG Yiping1,2,3
(1. School of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350108,China; 2. Technological Innovation Center for Marine Biological Resources Development and Utilization Engineering, Third Institute of Oceanography, Ministry of Natural Resources, Xiamen 361005,China; 3. School of Marine Biology, Xiamen Ocean Vocational and Technical College, Xiamen 361100,China)
Abstract:
Fucoidan have become a research hotspot because of their antioxidant, anti-inflammatory and anti-coagulant effects. The incidence of chronic renal failure (CRF) has been increasing year by year in recent years. Studies on the gut-renal axis have revealed a bidirectional regulation between the gut microflora (GM) and CRF, and the ability of GM to regulate the health of the body by balancing homeostasis has become a potential target for the treatment of CRF. Fucoidan are used as a microbial regulator to interfere with GM dysregulation and thus control the CRF process, preventing potential risk factors for accelerated renal failure. Therefore, this paper investigates the effects of Fucoidan on GM and CRF and the mechanism of bidirectional regulation of GM and CRF, and provides research directions and ideas for the subsequent development and utilization of Fucoidan.
Key words:  Fucoidan  Gut microflora  Chronic renal failure
Today's Visits:487    Total Visits:2383201
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.